Search Results for: CPRX
by H.S. AyoubBioHealth Investor.com Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored) Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it...
Published:
Catalyst Pharmaceuticals saw its shares get halved just Tuesday morning alone, following a business update regarding its Lambert-Eaton myasthenic syndrome treatment.
Published:
Last Updated:
Some small-cap companies will screen as having deep value, but many value stocks are deemed to be "cheap" because they lack any new catalysts and opportunities.
Published:
Robinhood has become the dominant discount brokerage platform over the last year. It had 4.3 million average revenue trades in June, which is a critical metric in the industry. This is higher than...
Published:
Wednesday's additional top analyst upgrades and downgrades were on Amazon.com, Beyond Meat, Catalyst Pharmaceuticals, Dick’s Sporting Goods, Macy’s, Medtronic, Twitter, XPeng and more.
Published:
Rite Aid has announced that it will acquire EnvisionRx for $2 billion from the private equity firm TPG Capital.
Published:
Source: ThinkstockCatalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) announced positive topline results from its Phase 3 clinical trial of Firdapse for the symptomatic treatment of Lambert-Eaton...
Published:
Some companies Robinhood traders find most attractive are very risky bets. A hit to the financials of one of these companies or a piece of bad news could easily trigger an extreme sell-off of the...
Published:
Apple, Twitter and other companies punished shareholders last week, and analysts expect more earnings disappointments going forward.
Published:
Last Updated:
The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) is up about 1% on the day,...
Published:
Last Updated:
The the top analyst upgrades, downgrades and initiations seen on Wednesday morning include Broadcom, Flex, Genworth Financial, Micron Technology, Salesforce.com, UBS and Wal-Mart.
Published:
Last Updated:
A new SunTrust Robinson Humphrey research report focuses in on biotech companies that have upcoming clinical data that could prove to be huge.
Published:
Last Updated:
In the week of October 7, there were multiple analyst calls for stocks to buy that were trading under $10 per share, including Petrobras and Brocade Communications.
Published:
Last Updated:
Tuesday's top analyst upgrades and downgrades included Applied Materials, Bill, Catalyst Pharmaceutical, CVS Health, Elastic, Hawaiian Electric Industries and Walmart.
Published:
Celator Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering.
Published:
Last Updated: